Outcomes Hematologic parameters | Model 1 HR (95% CI) | Model 2 HR (95% CI) |
---|---|---|
Rethinopathy (n = 161) |  |  |
 Haemoglobin | 0.57 (0.38–0.86)†| 0.65 (0.42–1.00) |
 RDW | 1.40 (0.95–2.07) | 1.49 (1.00–2.22) |
 Leukocytes | 1.33 (0.90–1.96) | 1.46 (0.97–2.19) |
 Neutrophyls | 1.03 (0.71–1.50) | 1.23 (0.83–1.82) |
 Lymphocytes | 1.20 (0.80–1.78) | 1.34 (0.89–2.02) |
 Monocytes | 1.19 (0.81–1.75) | 1.20 (0.80–1.80) |
 Platelets | 1.00 (0.68–1.48) | 1.07 (0.72–1.60) |
 Neutrophyl-to-lymphocyte ratio | 0.97 (0.66–1.43) | 0.97 (0.65–1.43) |
 Lymphocyte-to-monocyte ratio | 1.01 (0.68–1.49) | 1.18 (0.78–1.76) |
 Platelet-to-lymphocyte ratio | 0.93 (0.63–1.36) | 0.84 (0.57–1.24) |
 Monocyte-to-HDL ratio | 1.40 (0.97–2.02) | 1.38 (0.91–2.09) |
Renal composite (n = 206) |  |  |
 Haemoglobin | 0.67 (0.46–0.98)‡ | 0.67 (0.45–0.98)‡ |
 RDW | 1.13 (0.80–1.58) | 1.10 (0.78–1.55) |
 Leukocytes | 1.47 (1.04–2.09)‡ | 1.38 (0.97–1.98) |
 Neutrophyls | 1.25 (0.90–1.74) | 1.19 (0.85–1.67) |
 Lymphocytes | 1.14 (0.81–1.61) | 1.18 (0.82–1.69) |
 Monocytes | 1.18 (0.84–1.66) | 1.10 (0.77–1.57) |
 Platelets | 1.02 (0.71–1.47) | 1.06 (0.74–1.53) |
 Neutrophyl-to-lymphocyte ratio | 1.23 (0.88–1.71) | 1.13 (0.80–1.59) |
 Lymphocyte-to-monocyte ratio | 0.75 (0.52–1.07) | 0.78 (0.54–1.13) |
 Platelet-to-lymphocyte ratio | 1.04 (0.74–1.45) | 1.04 (0.74–1.47) |
 Monocyte-to-HDL ratio | 1.17 (0.84–1.64) | 1.04 (0.73–1.49) |
Microalbuminuria (n = 127) |  |  |
 Haemoglobin | 0.70 (0.43–1.13) | 0.65 (0.40–1.07) |
 RDW | 1.20 (0.77–1.86) | 1.22 (0.78–1.91) |
 Leukocytes | 1.55 (0.99–2.43) | 1.49 (0.95–2.35) |
 Neutrophyls | 1.43 (0.94–2.18) | 1.36 (0.88–2.09) |
 Lymphocytes | 1.09 (0.71–1.69) | 1.17 (0.74–1.84) |
 Monocytes | 1.01 (0.66–1.54) | 0.99 (0.64–1.53) |
 Platelets | 1.24 (0.77–1.99) | 1.22 (0.75–1.97) |
 Neutrophyl-to-lymphocyte ratio | 1.23 (0.81–1.86) | 1.12 (0.73–1.72) |
 Lymphocyte-to-monocyte ratio | 0.77 (0.48–1.21) | 0.80 (0.50–1.28) |
 Platelet-to-lymphocyte ratio | 1.02 (0.66–1.58) | 0.97 (0.62–1.51) |
 Monocyte-to-HDL ratio | 1.00 (0.64–1.55) | 0.95 (0.60–1.51) |
Renal failure (n = 104) |  |  |
 Haemoglobin | 0.50 (0.29–0.87)‡ | 0.58 (0.33–1.01) |
 RDW | 1.13 (0.69–1.83) | 1.10 (0.68–1.80) |
 Leukocytes | 1.35 (0.83–2.18) | 1.19 (0.73–1.95) |
 Neutrophyls | 1.17 (0.74–1.86) | 1.11 (0.69–1.78) |
 Lymphocytes | 1.10 (0.68–1.78) | 1.03 (0.62–1.71) |
 Monocytes | 1.67 (1.01–2.74)‡ | 1.50 (0.89–2.53) |
 Platelets | 0.82 (0.50–1.35) | 0.87 (0.53–1.45) |
 Neutrophyl-to-lymphocyte ratio | 1.54 (0.95–2.47) | 1.47 (0.90–2.41) |
 Lymphocyte-to-monocyte ratio | 0.56 (0.33–0.93)‡ | 0.58 (0.34–0.99)‡ |
 Platelet-to-lymphocyte ratio | 1.13 (0.72–1.79) | 1.17 (0.73–1.88) |
 Monocyte-to-HDL ratio | 1.30 (0.82–2.07) | 1.09 (0.66–1.81) |
Peripheral neuropathy (n = 179) |  |  |
 Haemoglobin | 0.70 (0.43–1.14) | 1.45 (0.80–2.64) |
 RDW | 1.56 (0.98–2.48) | 0.69 (0.39–1.21) |
 Leukocytes | 1.41 (0.89–2.22) | 1.35 (0.80–2.28) |
 Neutrophyls | 1.33 (0.84–2.10) | 1.33 (0.78–2.24) |
 Lymphocytes | 0.77 (0.48–1.23) | 0.79 (0.46–1.35) |
 Monocytes | 1.02 (0.65–1.61) | 0.98 (0.58–1.66) |
 Platelets | 0.92 (0.57–1.48) | 0.90 (0.52–1.56) |
 Neutrophyl-to-lymphocyte ratio | 1.54 (0.97–2.46) | 1.35 (0.79–2.31) |
 Lymphocyte-to-monocyte ratio | 0.76 (0.47–1.23) | 0.75 (0.43–1.30) |
 Platelet-to-lymphocyte ratio | 0.90 (0.57–1.41) | 0.92 (0.54–1.54) |
 Monocyte-to-HDL ratio | 1.24 (0.79–1.95) | 1.41 (0.82–2.43) |